Recent advances in the synthesis of Quinazoline analogues as Anti-TB agents

被引:40
|
作者
Dutta, Apurba [1 ]
Sarma, Diganta [1 ]
机构
[1] Dibrugarh Univ, Dept Chem, Dibrugarh 786004, Assam, India
关键词
Mycobacterium tuberculosis; Anti-tubercular drugs; Heterocyclic chemistry; Quinazoline analogues; Structure-activity relationship; BIOLOGICAL EVALUATION; EFFICIENT SYNTHESIS; ADHATODA-VASICA; DERIVATIVES; CATALYST; DESIGN; 1,2-DIHYDROQUINAZOLIN-4(3H)-ONES; ALDEHYDES; SAMARIUM; WATER;
D O I
10.1016/j.tube.2020.101986
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Quinazoline analogues are one of the important nitrogen containing heterocycles that have significant bioactivity as well as found in a plethora of natural products. Tuberculosis is one of the serious universal health threats caused by Mycobacterium tuberculosis (MTB) and primarily affects the lungs. Due to their significant bioactivity and natural occurrences of quinazolines, researchers are trying to synthesize new quinazoline analogues which may have significant potency against tuberculosis. This particular review summarizes recent development of different types of quinazoline bearing analogues as anti-tubercular (anti-TB) agents and their synthesis with structure-activity relationship.
引用
收藏
页数:19
相关论文
共 50 条
  • [31] Quinazoline-tethered hydrazone: A versatile scaffold toward dual anti-TB and EGFR inhibition activities in NSCLC
    Emam, Aya M.
    Dahal, Achyut
    Singh, Sitanshu S.
    Tosso, Rodrigo D.
    Ibrahim, Samy M.
    El-Sadek, Mohamed
    Jois, Seetharama D.
    Enriz, Ricardo D.
    Kothayer, Hend
    ARCHIV DER PHARMAZIE, 2021, 354 (12)
  • [32] Imidazopyridine Hydrazine Conjugates as Potent Anti-TB Agents with their Docking, SAR, and DFT Studies
    Soumyashree, D. K.
    Reddy, Dinesh S.
    Kumari, M. Sunitha
    Ravikumar, R.
    Kumar, Amit
    Nagarajaiah, H.
    Vidya, G.
    Naik, Lohit
    Al-Asbahi, Bandar Ali
    Kadam, Nikhil
    Shanavaz, H.
    Padmashali, Basavaraj
    CHEMISTRYSELECT, 2024, 9 (20):
  • [33] Structure-based drug design, synthesis and screening of MmaA1 inhibitors as novel anti-TB agents
    Hymavathi Veeravarapu
    Vasavi Malkhed
    Kiran Kumar Mustyala
    Rajender Vadija
    Ramesh Malikanti
    Uma Vuruputuri
    Murali Krishna Kumar Muthyala
    Molecular Diversity, 2021, 25 : 351 - 366
  • [34] Recent advances in the synthesis of antifungal agents
    Barrett, AGM
    Doubleday, WW
    Hamprecht, D
    Kasdorf, K
    Tustin, GJ
    PURE AND APPLIED CHEMISTRY, 1997, 69 (03) : 383 - 388
  • [35] Structure-based drug design, synthesis and screening of MmaA1 inhibitors as novel anti-TB agents
    Veeravarapu, Hymavathi
    Malkhed, Vasavi
    Mustyala, Kiran Kumar
    Vadija, Rajender
    Malikanti, Ramesh
    Vuruputuri, Uma
    Muthyala, Murali Krishna Kumar
    MOLECULAR DIVERSITY, 2021, 25 (01) : 351 - 366
  • [36] Models and approaches for anti-TB drug testing
    Yasinskaya, Yuliya
    Sacks, Leonard
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2011, 9 (07) : 823 - 831
  • [37] Design, synthesis and anti-Tb evaluation of chalcone derivatives as novel inhibitors of InhA
    Dhivya, L. S.
    Kathiravan, M. K.
    Thamilselvan, Gopalakrishnan
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2023, 41 (24): : 15165 - 15176
  • [38] Observations on malnutrition and anti-TB drugs in Ghana
    Muyou, A. J.
    Kunasagran, P. D.
    Rahim, S. S. Syed Abdul
    Avoi, R.
    Hayati, F.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2021, 25 (09) : 778 - 779
  • [39] The Anti-TB Structural Center at ShanghaiTech University
    Yang, Haitao
    STRUCTURE, 2025, 33 (02) : 207 - 212
  • [40] Possible Protective Effect of Chalcone Analogues Against Anti-Tb Drugs Induced Hepatocellular Damage in Rats
    Kalia, Shikha
    Sharma, Gargi
    Sapra, Sameer
    Goyal, Rohit
    INDIAN JOURNAL OF PHARMACOLOGY, 2013, 45 : S85 - S85